Centessa Pharmaceuticals plc
CNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,917,423 | $765,577 | $289,543 | $1,013,265 |
| - Cash | $383,221 | $128,030 | $393,644 | $595,082 |
| + Debt | $117,226 | $84,588 | $69,800 | $75,700 |
| Enterprise Value | $1,651,428 | $722,135 | -$34,301 | $493,883 |
| Revenue | $0 | $6,853 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $6,853 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$221,881 | -$165,425 | -$209,546 | -$139,297 |
| % Margin | – | -2,413.9% | – | – |
| Net Income | -$235,757 | -$151,085 | -$216,207 | -$381,900 |
| % Margin | – | -2,204.7% | – | – |
| EPS Diluted | -2.06 | -1.57 | -2.31 | -4.24 |
| % Growth | -31.2% | 32% | 45.5% | – |
| Operating Cash Flow | -$142,055 | -$160,342 | -$200,546 | -$136,142 |
| Capital Expenditures | -$34 | -$169 | -$1,137 | -$186 |
| Free Cash Flow | -$142,089 | -$160,511 | -$201,683 | -$136,328 |